Hims & Hers Health, Inc. — Form 8-K Summary
Business context and reporting period
The filing reports a corporate governance event dated February 16, 2023. It is not a quarterly or annual financial results filing and does not provide operating or financial-period data.
Material event
- The Board increased its size from ten to eleven directors.
- Christiane Pendarvis, age 52, was appointed to the newly created director position effective February 16, 2023.
- She will serve until the 2023 annual meeting of stockholders and until her successor is elected and qualified, unless her service ends earlier.
- The Board determined that Ms. Pendarvis is independent under applicable NYSE listing standards and the Securities Exchange Act.
- She was not assigned to a standing Board committee at the time of appointment.
Financial metrics, compensation, and liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating metrics.
Ms. Pendarvis will receive compensation under the Company’s existing director compensation program and will enter into the Company’s standard indemnification agreement. The filing does not state the dollar value of her compensation.
Management commentary, risks, and unusual items
- The filing states that there were no arrangements or understandings with other persons relating to Ms. Pendarvis’s election.
- No family relationships with directors, executive officers, or director or executive-officer nominees were reported.
- Ms. Pendarvis was not party to any current or proposed transaction requiring disclosure under Item 404(a) of Regulation S-K.
- No specific risks, contingencies, or changes to business outlook were disclosed.
Key facts for investors to verify
- Confirm the appointment date and the expected term through the 2023 annual meeting.
- Review the Company’s director compensation program for the applicable cash and equity awards.
- Monitor future filings for committee assignments, additional governance changes, and any related-party transactions.
- Note that the report was signed on February 23, 2023, while the earliest reported event occurred on February 16, 2023.